Skip to main content
Caplight Logo









Innova Vascular

Innova Vascular

Private
Irvine, CaliforniaHealthcare & Life Scienceshttps://innovavascular.com/

Last Round

Series A

Sep 11, 2025

Total Funding Raised

$10M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Innova Vascular is a medical device company that develops and commercializes minimally invasive solutions for treating vascular diseases, including venous thromboembolism.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

thrombectomymechanical thrombectomyaspiration cathetervascular interventionclot removalperipheral vascularminimally invasivemedical devicethromboembolism treatmentinterventional radiologyvascular surgeryclot retrieverthrombectomy deviceendovascular

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Innova Vascular Comparables

Compare Innova Vascular with similar companies based on industry and business-model similarity.

Innova Vascular comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Thrombolex, Inc.
91%
Caeli Vascular, Inc.
88%
Contego Medical
81%

Innova Vascular Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series ASep 11, 2025
AcceleratorMay 29, 2024
StrategicFeb 23, 2022

Key People

Founding team and executive leadership

Sanjay Shrivastava

Chief Executive Officer

Executive Team

Innova Vascular Investors

Notable investors and investment history

Innova Vascular investors
InvestorRounds
MedTech InnovatorAccelerator
GEO MedTech VenturesSeries A
Black Diamond VenturesSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 31, 2026

    Grew 27% QoQ, from 11 to 14 employees.

  • May 17, 2026

    Monthly visitors grew 100% MoM.

Innova Vascular Filings

Explore SEC and related filing metadata, where available.

Innova Vascular filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Innova Vascular's valuation, stock price, and market status.

Is Innova Vascular a public or private company?

Innova Vascular is a private company.

What is the current stock price of Innova Vascular?

Innova Vascular is a private company with no public stock price. No recent secondary market data is available.

How much is Innova Vascular worth (valuation)?

Valuation information for Innova Vascular is not publicly available.

Can I buy Innova Vascular stock?

Innova Vascular shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Innova Vascular's last funding round?

Innova Vascular's most recent funding round was Accelerator on May 29, 2024.

Who are the main investors in Innova Vascular?

Key investors in Innova Vascular include MedTech Innovator.

Will Innova Vascular IPO soon?

No public IPO plans have been announced for Innova Vascular.

How can I track Innova Vascular secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Innova Vascular's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersIrvine, California
Employee Range9
Year Founded2018
Last FundingSep 11, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?